Literature DB >> 14570283

Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.

JangBo Lee1, Satoshi Kuroda, Hideo Shichinohe, Jun Ikeda, Toshitaka Seki, Kazutoshi Hida, Mitsuhiro Tada, Ken-ichi Sawada, Yoshinobu Iwasaki.   

Abstract

There is increasing evidence that bone marrow stromal cells (BMSC) have the potential to migrate into the injured neural tissue and to differentiate into the CNS cells, indicating the possibility of autograft transplantation therapy. The present study was aimed to clarify whether the mouse BMSC can migrate into the lesion and differentiate into the CNS cells when transplanted into the mice subjected to focal cerebral infarct or spinal cord injury. The BMSC were harvested from mice and characterized by flow cytometry. Then, the BMSC were labeled by bis-benzimide, a nuclear fluorescence dye, over 24 h, and were stereotactically transplanted into the brain or spinal cord of the mice. The cultured BMSC expressed low levels of CD45 and high levels of CD90 and Sca-1 on flow cytometry. A large number of grafted cells survived in the normal brain 4 weeks after transplantation, many of which were located close to the transplanted sites. They expressed the neuronal marker including NeuN, MAP2, and doublecortin on fluorescent immunohistochemistry. However, when the BMSC were transplanted into the ipsilateral striatum of the mice subjected to middle cerebral artery occlusion, many of the grafted cells migrated into the corpus callosum and injured cortex, and also expressed the neuronal markers 4 weeks after transplantation. In particular, NeuN was very useful to validate the differentiation of the grafted cells, because the marker was expressed in the nuclei and was overlapped with bis-benzimide. Similar results were obtained in the mice subjected to spinal cord injury. However, many of the transplanted BMSC expressed GFAP, an astrocytic protein, in injured spinal cord. The present results indicate that the mouse BMSC can migrate into the CNS lesion and differentiate into the neurons or astrocytes, and that bis-benzimide is a simple and useful marker to label the donor cells and to evaluate their migration and differentiation in the host neural tissues over a long period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570283     DOI: 10.1046/j.1440-1789.2003.00496.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  50 in total

Review 1.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

2.  Effect of IKVAV peptide nanofiber on proliferation, adhesion and differentiation into neurocytes of bone marrow stromal cells.

Authors:  Bin Wu; Qixin Zheng; Yongchao Wu; Xiaodong Guo; Zhenwei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

3.  In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair.

Authors:  Noelle Comolli; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman
Journal:  Acta Biomater       Date:  2008-10-26       Impact factor: 8.947

4.  Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats-a serial MRI study.

Authors:  Masaki Ito; Satoshi Kuroda; Taku Sugiyama; Hideo Shichinohe; Yukari Takeda; Mitsufumi Nishio; Takao Koike; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-07-26       Impact factor: 6.829

5.  Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells.

Authors:  Yasumasa Kuroda; Shohei Wakao; Masaaki Kitada; Toru Murakami; Makoto Nojima; Mari Dezawa
Journal:  Nat Protoc       Date:  2013-06-20       Impact factor: 13.491

Review 6.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

7.  IFATS collection: Stem cell antigen-1-positive ear mesenchymal stem cells display enhanced adipogenic potential.

Authors:  Jaroslaw Staszkiewicz; Jeffrey M Gimble; Jessica A Manuel; Barbara Gawronska-Kozak
Journal:  Stem Cells       Date:  2008-07-03       Impact factor: 6.277

Review 8.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

9.  Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori; Mitsufumi Nishio; Yukari Takeda; Takao Koike; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-06-11       Impact factor: 6.829

10.  Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Kohsuke Kudo; Masaki Ito; Masahito Kawabori; Michiyuki Miyamoto; Mitsuhiro Nakanishi; Satoshi Terae; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.